Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
MacroGenics Inc.

Start price
Target price
Perf. (%)
€16.79
19.09.21
-
19.09.22
-79.51%
20.09.22

Probably not worthwhile Investment
Lokrim 
19.09.21 20%
sell
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€25.05
19.09.21
-
19.09.22
-85.23%
20.09.22

Growths faster than the competition
Risky Investment
Lokrim 
19.09.21 10%
sell
Celyad SA ADR

Start price
Target price
Perf. (%)
€3.58
19.09.21
-
19.09.22
-53.35%
20.09.22

Probably not worthwhile Investment
Lokrim 
19.09.21 10%
sell
Burcon Nutrascience Corp.

Start price
Target price
Perf. (%)
€1.53
19.09.21
-
19.09.22
-75.74%
20.09.22

Probably not worthwhile Investment
Lokrim 
19.09.21 10%
sell
Heat Biologics Inc.

Start price
Target price
Perf. (%)
€5.30
18.09.21
-
18.09.22
-63.56%
19.09.22

Risky Investment
High risks for its business
Dependend from few customers or products
Shooter 
18.09.21 50%
buy
Blackrock I-br Adv.eu. Equ.

Start price
Target price
Perf. (%)
€126.55
18.09.21
-
18.09.22
-2.66%
19.09.22

Could be worthwhile Investment >10% per year
melinda 
18.09.21 50%
buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.20
18.09.21
€10.00
31.12.23
-79.42%
08.05.23

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
18.09.21 70%
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€12.54
18.09.21
€20.00
31.12.23
-52.05%
08.05.23

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
18.09.21 60%
buy
Spectrum Pharmaceuticals

Start price
Target price
Perf. (%)
€2.60
18.09.21
€5.00
31.12.23
-62.67%
08.05.23

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
18.09.21 50%
buy
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.20
18.09.21
€40.00
31.12.23
61.97%
16.12.21

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
18.09.21 70%
buy
ASLAN Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€13.30
18.09.21
€20.00
31.12.23
-76.88%
08.05.23

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
18.09.21 60%
sell
Nel ASA

Start price
Target price
Perf. (%)
€1.27
18.09.21
-
18.09.22
28.81%
10.12.21

Commando 
18.09.21 50%
buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.99
18.09.21
€44.00
18.09.22
-1.42%
27.05.22

mariusz 
18.09.21 50%
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€2.94
18.09.21
€555.00
18.09.22
-62.70%
27.05.22

Could be very worthwhile Investment >20% year
mariusz 
18.09.21 50%
buy
Eurofins Scientific SE

Start price
Target price
Perf. (%)
€126.14
18.09.21
€200.00
18.09.22
-34.99%
19.05.22

jintapo 
18.09.21 90%
buy
Bevcanna Enterprises Inc.

Start price
Target price
Perf. (%)
€0.26
18.09.21
€2.00
18.09.22
-84.35%
16.07.22

Leading role in innovation
Small cyclical dependencies
Well known brand
Very Future proof/growth oriented business model
MarioMW007 
18.09.21 100%
sell
Innate Pharma

Start price
Target price
Perf. (%)
€6.61
18.09.21
€3.00
18.09.22
-22.01%
02.10.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
nvestor 
18.09.21 50%
sell
Innate Pharma S.a.

Start price
Target price
Perf. (%)
€6.60
18.09.21
€3.00
18.09.22
-26.06%
02.10.21

Lower EBIT Margin than peer group
Bad rating
Increased challenges to pay loans and raise capital
Below average Management
nvestor 
18.09.21 50%
sell
micromobility.com Inc.

Start price
Target price
Perf. (%)
€693.90
18.09.21
€350.00
18.09.22
-22.18%
02.10.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Low dividend yield expected
nvestor 
18.09.21 50%
sell
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.20
18.09.21
€2.00
18.09.22
-22.69%
02.10.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
nvestor 
18.09.21 50%
sell
First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€675.52
18.09.21
€209.79
18.09.22
-25.47%
02.10.21

Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
nvestor 
18.09.21 50%
sell
China HGS Real Estate Inc

Start price
Target price
Perf. (%)
€1.27
18.09.21
€0.000
18.09.22
-2.36%
22.01.22

mixitrader 
18.09.21 50%
sell
Isoenergy Ltd

Start price
Target price
Perf. (%)
€3.46
18.09.21
€1.00
18.09.22
-19.94%
02.10.21

mixitrader 
18.09.21 50%
sell
TCR2 Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.60
18.09.21
€4.00
18.09.22
-16.28%
02.10.21

mixitrader 
18.09.21 50%
sell
Greenidge Generation Holdings Inc.

Start price
Target price
Perf. (%)
€9.95
18.09.21
€4.00
-
02.10.21

mixitrader 
18.09.21 50%